Name: XORTX THERAPEUTICS INC (XRTX) Stock
Brand: XORTX THERAPEUTICS INC
Rating: 3.5 (3 reviews)

XRTX Latest News, Press Relases and Analysis

All

Press Releases

a month ago - By: Benzinga - Mentions: ZOOZ EPWK TAIT WAI ...

Why Lucas GC Shares Are Trading Higher By Over 36%; Here Are 20 Stocks Moving Premarket

a month ago - By: XORTX Therapeutics Inc. - Mentions: XRTX.CA

XORTX Announces Closing of US$1.1 Million Registered Direct Offering

2 months ago - By: XORTX Therapeutics Inc. - Mentions: XRTX.CA

XORTX Announces Pricing of US$1.1 Million Registered Direct Offering

2 months ago - By: XORTX Therapeutics Inc. - Mentions: XRTX.CA

XORTX Issues Correction Notice and XORTX Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price Deficiency

2 months ago - By: XORTX Therapeutics Inc. - Mentions: XRTX.CA

XORTX Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

7 months ago - By: XORTX Therapeutics Inc. - Mentions: XRTX.CA

XORTX Announces USD $3 Million Offering

10 months ago - By: XORTX Therapeutics Inc. - Mentions: XRTX.CA

XORTX to Present at Microcap Conference

a year ago - By: XORTX Therapeutics Inc. - Mentions: XRTX.CA

XORTX Announces Change of Auditor

2 months ago - By: Benzinga - Mentions: NBY REPL RAPT ADAP ...

12 Health Care Stocks Moving In Monday's Intraday Session

a year ago - By: XORTX Therapeutics Inc. - Mentions: XRTX.CA

XORTX Strengthens Executive Team

2 months ago - By: XORTX Therapeutics Inc. - Mentions: XRTX.CA

XORTX Announces Acquisition of Renal Anti-Fibrotic Therapeutic Program from Vectus Biosystems

3 months ago - By: XORTX Therapeutics Inc. - Mentions: XRTX.CA

Join XORTX for an Exclusive Live Investor Webinar and Q&A Session on September 10

3 months ago - By: XORTX Therapeutics Inc. - Mentions: XRTX.CA

XORTX Initiates IND Preparation for XORLO™ in Gout Program

4 months ago - By: XORTX Therapeutics Inc. - Mentions: XRTX.CA

XORTX Completes USD $114,500 Private Placement

5 months ago - By: XORTX Therapeutics Inc. - Mentions: XRTX.CA

XORTX Completes Non-Brokered Private Placement of Units

5 months ago - By: XORTX Therapeutics Inc. - Mentions: XRTX.CA

XORTX Announces USD $925,000 Private Placement

8 months ago - By: XORTX Therapeutics Inc. - Mentions: XRTX.CA

XORTX Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

9 months ago - By: XORTX Therapeutics Inc. - Mentions: XRTX.CA

XORTX Announces Update for Discussion with the FDA

9 months ago - By: XORTX Therapeutics Inc. - Mentions: XRTX.CA

XORTX Commences Gout Program NDA Discussions with the FDA

a year ago - By: XORTX Therapeutics Inc. - Mentions: XRTX.CA

XORTX Announces Presentation at the Rare and Genetic Disease Summit

a year ago - By: XORTX Therapeutics Inc. - Mentions: XRTX.CA

XORTX Announces Closing of US$1.5 Million Registered Direct Offering and Concurrent Private Placement

a year ago - By: XORTX Therapeutics Inc. - Mentions: XRTX.CA

XORTX Announces Pricing of US$1.5 Million Registered Direct Offering and Concurrent Private Placement

a year ago - By: XORTX Therapeutics Inc. - Mentions: XRTX.CA

XORTX Initiates Precision Medicine Program

a year ago - By: XORTX Therapeutics Inc. - Mentions: XRTX.CA

XORTX Announces Results of Annual and Special Meeting of Shareholders

a year ago - By: XORTX Therapeutics Inc. - Mentions: XRTX.CA

XORTX THERAPEUTICS INC (XRTX) Stock News

XRTX Latest News, Press Relases and Analysis

Why Lucas GC Shares Are Trading Higher By Over 36%; Here Are 20 Stocks Moving Premarket

XORTX Announces Closing of US$1.1 Million Registered Direct Offering

XORTX Announces Pricing of US$1.1 Million Registered Direct Offering

XORTX Issues Correction Notice and XORTX Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price Deficiency

XORTX Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

XORTX Announces USD $3 Million Offering

XORTX to Present at Microcap Conference

XORTX Announces Change of Auditor

12 Health Care Stocks Moving In Monday's Intraday Session

XORTX Strengthens Executive Team

XORTX Announces Acquisition of Renal Anti-Fibrotic Therapeutic Program from Vectus Biosystems

Join XORTX for an Exclusive Live Investor Webinar and Q&A Session on September 10

XORTX Initiates IND Preparation for XORLO™ in Gout Program

XORTX Completes USD $114,500 Private Placement

XORTX Completes Non-Brokered Private Placement of Units

XORTX Announces USD $925,000 Private Placement

XORTX Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

XORTX Announces Update for Discussion with the FDA

XORTX Commences Gout Program NDA Discussions with the FDA

XORTX Announces Presentation at the Rare and Genetic Disease Summit

XORTX Announces Closing of US$1.5 Million Registered Direct Offering and Concurrent Private Placement

XORTX Announces Pricing of US$1.5 Million Registered Direct Offering and Concurrent Private Placement

XORTX Initiates Precision Medicine Program

XORTX Announces Results of Annual and Special Meeting of Shareholders

XORTX Announces Re-filing of YE 2023 and Q2 2024 MD&A